Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients

NCT01453257 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Progression Free Survival

Interventions

DRUG: Tailored Chemotherapy

Sponsor

Grupo Hospital de Madrid